antibiotic whose range of antibacterial activity is in most respects similar to that of aureomycin, may have slight anti-tuberculous activity. This, however, is manifest, if at all, only with very large doses, and no results of clinical trials are yet available.
Summary
At present the administration of streptomycin intramuscularly concurrently with para-aminosalicylic acid by mouth is the standard method of anti-bacterial treatment in pulmonary tuberculosis.
The investigations which have led to the general adoption of this combined treatment are outlined and current indications for its use briefly discussed.
Though streptomycin has serious toxic effects and limitations imposed by the ability of tubercle bacilli to become resistant to its action, investigations of-some newer antibiotics hold no promise that any so far discovered can replace it. 
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